EP Patent

EP1734962A4 — COMPOSITIONS AND METHODS FOR IONIC CHANNEL MODULATION CONTROLLED BY DOOR

Assigned to Painceptor Pharma Corp · Expires 2010-07-14 · 16y expired

What this patent protects

Patent listed against dextromethorphan-hydrobromide.

Drugs covered by this patent

dextromethorphan-hydrobromide (DEXTROMETHORPHAN HYDROBROMIDE)

Patent Metadata

Patent number: EP1734962A4
Jurisdiction: EP
Classification: —
Expires: 2010-07-14
Drug substance claim: No
Drug product claim: No
Assignee: Painceptor Pharma Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.